Lilly lung cancer drug boosts survival, shares jump
(Reuters) - An experimental Eli Lilly and Co lung cancer drug that some investors had given up on due to past setbacks, extended patient survival in a...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/-fsgHUBgQ2k/story01.htm
No comments:
Post a Comment